🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of rapid British shipping. Vendors market the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.

Several experts stated the popularity for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.

Service Reaction and Material Elimination

According to the social media company, the platform has removed problematic content and banned related hashtags and search suggestions. The organization said it was committed to keeping the platform safe and investing in enhancing compliance measures.

Online Trading Activities

Research also discovered communities with up to nine thousand members selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of weight loss, glowing reviews and detailed guides for preparing or administering at residence.

Within moments of entering one community, a vendor shared contact information, where most purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, health issues or past usage.

Product Details and Costs

Inside these communities, posts show black plastic packages with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has already encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to potentially serious health risks”.